Recipharm Expands Lyophilization Capacity in Italy
PTSM: Pharmaceutical Technology Sourcing and Management
Recipharm is investing EUR3.7 million (approximately $4.18 million) to increase lyophilization capacity at its Masate facility in Italy.
CDMO Recipharm has announced plans to expand its lyophilization capacity in Masate, Italy, to meet growing customer demand. An investment of EUR3.7 million (approximately $4.18 million) has been set aside for this expansion. A new lyophilizer will be purchased, bringing the total number of machines from five to six.
The CDMO offers lyophilization services for both vials and ampoules. The Masate facility specializes in aseptic manufacturing of parenterals.
Recipharm also invested EUR32 million (approximately $36 million) in Wasserburg, Germany in an ongoing project to increase lyophilization capacity at that site.
Source: Recipharm
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
